{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:18:41Z","timestamp":1754396321737,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hyperchloremic metabolic acidosis that develops during the treatment of diabetic ketoacidosis is usually attributed to the chloride content of resuscitation fluids. We explored an alternative explanation, namely that fluid-induced plasma volume expansion alters the absolute differences in the concentrations of sodium and chloride (the Na\u2013Cl gap) enough to affect the acid\u2013base balance. We analyzed data from a prospective single-center cohort study of 14 patients treated for diabetic ketoacidosis. All patients received 1 L of 0.9% saline over 30\u00a0min on two consecutive days. Blood gases were sampled before and after the infusions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The initial plasma volume was estimated to be 25\u2009\u00b1\u200913% (mean\u2009\u00b1\u2009SD) below normal on admission to the intensive care unit. At that time, most patients had an increased actual Na\u2013Cl gap, which counteracts acidosis. However, the correction of the plasma volume deficit revealed that these patients would have had a decreased Na\u2013Cl gap upon admission if they had been normovolemic at that time; the estimated \u201cvirtual Na\u2013Cl gap\u201d of 29\u2009\u00b1\u20095\u00a0mmol\/L was significantly lower than the uncorrected value, which was 39\u2009\u00b1\u20095\u00a0mmol\/L (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). On Day 2, most patients had a decreased actual Na\u2013Cl gap (33\u2009\u00b1\u20095\u00a0mmol\/L), approaching the corrected value on Day 1<jats:italic>.<\/jats:italic><\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The hyperchloremic acidosis commonly seen in diabetic ketoacidosis may not be primarily caused by the chloride content of resuscitation fluids but, rather, by the restoration of plasma volume, which reveals the hidden metabolic acidosis caused by a decreased Na\u2013Cl gap.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> Clinical Trials Identifier NCT02172092, registered June 24, 2014, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/NCT02172092\">https:\/\/www.clinicaltrials.gov\/NCT02172092<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40635-022-00464-5","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T16:03:56Z","timestamp":1661789036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Plasma volume expansion reveals hidden metabolic acidosis in patients with diabetic ketoacidosis"],"prefix":"10.1186","volume":"10","author":[{"given":"Robert","family":"Svensson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1528-3803","authenticated-orcid":false,"given":"Robert G.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim H.","family":"Zdolsek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Bahlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"464_CR1","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.ajem.2010.02.004","volume":"29","author":"SA Mahler","year":"2011","unstructured":"Mahler SA, Conrad SA, Wang H, Arnold TC (2011) Resuscitation with balanced electrolyte solution prevents hyperchloremic metabolic acidosis in patients with diabetic ketoacidosis. Am J Emerg Med 29:670\u2013674","journal-title":"Am J Emerg Med"},{"key":"464_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jcrc.2012.01.007","volume":"27","author":"HR Chua","year":"2012","unstructured":"Chua HR, Venkatesh B, Stachowski E, Schneider AG, Perkins K, Ladanyi S, Kruger P, Bellomo R (2012) Plasma-Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosis. J Crit Care 27:138\u2013145","journal-title":"J Crit Care"},{"key":"464_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fendo.2017.00106","volume":"8","author":"TTT Tran","year":"2017","unstructured":"Tran TTT, Pease A, Wood AJ, Zajac JD, M\u00e5rtensson J, Bellomo R, Ekinci EII (2017) Review of evidence for adult diabetic ketoacidosis management protocols. Front Endocrinol (Lausanne) 8:106","journal-title":"Front Endocrinol (Lausanne)"},{"key":"464_CR4","volume-title":"How to understand acid-base. A quantitative acid-base primer for biology and medicine","author":"PA Stewart","year":"1981","unstructured":"Stewart PA (1981) How to understand acid-base. A quantitative acid-base primer for biology and medicine. Elsevier, New York"},{"key":"464_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.trsl.2010.09.006","volume":"157","author":"K Hopper","year":"2011","unstructured":"Hopper K, Haskins SC (2011) The acid-base effects of free water removal from and addition to oxygenated and deoxygenated whole blood: an in vitro model of contraction alkalosis and dilutional acidosis. Transl Res 157:29\u201337","journal-title":"Transl Res"},{"key":"464_CR6","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/aas.13614","volume":"64","author":"RG Hahn","year":"2020","unstructured":"Hahn RG, Svensson R, Zdolsek JH (2020) Kinetics of crystalloid fluid in hyperglycemia; an open-label exploratory clinical trial. Acta Anaesthesiol Scand 64:1177\u20131186","journal-title":"Acta Anaesthesiol Scand"},{"key":"464_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1213\/ANE.0000000000001261","volume":"123","author":"DA Story","year":"2016","unstructured":"Story DA (2016) Stewart acid-base: a simplified bedside approach. Anesth Analg 123:511\u2013515","journal-title":"Anesth Analg"},{"key":"464_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/qjmed\/hcr226","volume":"105","author":"DG Van Zyl","year":"2012","unstructured":"Van Zyl DG, Rheeder P, Delport E (2012) Fluid management in diabetic-acidosis\u2014Ringer\u2019s lactate versus normal saline: a randomized controlled trial. QJM 105:337\u2013343","journal-title":"QJM"},{"key":"464_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-019-2683-3","volume":"24","author":"V Williams","year":"2020","unstructured":"Williams V, Jayashree M, Nallasamy K, Dayal D, Rawat A (2020) 0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial. Crit Care 24:1","journal-title":"Crit Care"},{"key":"464_CR10","doi-asserted-by":"publisher","first-page":"e2024596","DOI":"10.1001\/jamanetworkopen.2020.24596","volume":"3","author":"WH Self","year":"2020","unstructured":"Self WH, Evans CS, Jenkins CA, Brown RM, Casey JD, Collins SP, Coston TD, Felbinger M, Flemmons LN, Hellervik SM, Lindsell CJ, Liu D, McCoin NS, Niswender KD, Slovis CM, Stollings JL, Wang L, Rice TW, Semler MW et al (2020) Clinical effects of balanced crystalloids vs saline in adults with diabetic ketoacidosis: a subgroup analysis of cluster randomized clinical trials. JAMA Netw Open 3:e2024596","journal-title":"JAMA Netw Open"},{"key":"464_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/0018578718757517","volume":"53","author":"WD Oliver","year":"2018","unstructured":"Oliver WD, Willis GC, Hines MC, Hayes BD (2018) Comparison of Plasma-Lyte A and sodium chloride 0.9% for fluid resuscitation of patients with diabetic ketoacidosis. Hosp Pharm 53:326\u2013330","journal-title":"Hosp Pharm"},{"key":"464_CR12","first-page":"1248","volume":"47","author":"Ramanan M, Attokaran A, Murray L, Bhadange N, Stewart D, Rajendran G, Pusapati R, Petty M, Garrett P, Kruger P, Peake S, Billot L, Venkatesh B: SCOPE-DKA Collaborators and Queensland Critical Care Research Network (QCCRN)","year":"2021","unstructured":"Ramanan M, Attokaran A, Murray L, Bhadange N, Stewart D, Rajendran G, Pusapati R, Petty M, Garrett P, Kruger P, Peake S, Billot L, Venkatesh B: SCOPE-DKA Collaborators and Queensland Critical Care Research Network (QCCRN) (2021) Sodium chloride or Plasmalyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA): A cluster, crossover, randomized, controlled trial. Intensive Care Med 47:1248\u20131257","journal-title":"Intensive Care Med"},{"issue":"1","key":"464_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000613","volume":"4","author":"NA Alghamdi","year":"2022","unstructured":"Alghamdi NA, Major P, Chaudhuri D, Tsui J, Brown B, Self WH, Semler MW, Ramanan M, Rochwerg B (2022) Saline compared to balanced crystalloid in patients with diabetic ketoacidosis: A systematic review and meta-analysis of randomized controlled trials. Crit Care Explor 4(1):e0613","journal-title":"Crit Care Explor"},{"key":"464_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jcrc.2010.08.013","volume":"26","author":"AD Lopes","year":"2011","unstructured":"Lopes AD, Maciel AT, Park M (2011) Evolutive physicochemical characterization of diabetic ketoacidosis in adult patients admitted to the intensive care unit. J Crit Care 26:303\u2013310","journal-title":"J Crit Care"},{"key":"464_CR15","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1590\/S1807-59322009000700018","volume":"64","author":"AT Maciel","year":"2009","unstructured":"Maciel AT, Park M (2009) A physicochemical acid-base approach for managing diabetic ketoacidosis. Clinics (Sao Paulo) 64:714\u2013718","journal-title":"Clinics (Sao Paulo)"},{"key":"464_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.5603\/AIT.2013.0044","volume":"45","author":"J Szrama","year":"2013","unstructured":"Szrama J, Smuszkiewicz P (2013) Acid-base disorder analysis during diabetic ketoacidosis using the Stewart approach - a case report. Anaesthesiol Intensive Ther 45:230\u2013234","journal-title":"Anaesthesiol Intensive Ther"},{"key":"464_CR17","first-page":"12","volume":"7","author":"G Dimeski","year":"2005","unstructured":"Dimeski G, Barnett RJ (2005) Effects of total plasma protein concentration on plasma sodium, potassium and chloride measurements by an indirect ion selective electrode measuring system. Crit Care Resusc 7:12\u201315","journal-title":"Crit Care Resusc"},{"key":"464_CR18","volume-title":"Stewart\u2019s Textbook of Acid-base","author":"A Durward","year":"2009","unstructured":"Durward A, Tibby SM (2009) Pediatrics. In: Kellum JA, Elbers PWG (eds) Stewart\u2019s Textbook of Acid-base, 2nd edn. Lulu Pres, Morrisville","edition":"2"},{"key":"464_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/cc644","volume":"4","author":"JA Kellum","year":"2000","unstructured":"Kellum JA (2000) Determinants of blood pH in health and disease. Crit Care 4:6\u201314","journal-title":"Crit Care"},{"key":"464_CR20","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1164\/ajrccm.162.6.9904099","volume":"162","author":"V Fencl","year":"2000","unstructured":"Fencl V, Jabor A, Kazda A, Figge J (2000) Diagnosis of metabolic acid-base disturbances in critically ill patients. Am J Respir Crit Care Med 162:2246\u20132251","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-022-00464-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-022-00464-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-022-00464-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T16:07:14Z","timestamp":1661789234000},"score":1,"resource":{"primary":{"URL":"https:\/\/icm-experimental.springeropen.com\/articles\/10.1186\/s40635-022-00464-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["464"],"URL":"https:\/\/doi.org\/10.1186\/s40635-022-00464-5","relation":{},"ISSN":["2197-425X"],"issn-type":[{"type":"electronic","value":"2197-425X"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"assertion":[{"value":"3 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Regional Ethics Committee of Link\u00f6ping (2014\/123\u201331) and was conducted in compliance with the Declaration of Helsinki. The patients consented to participate after having received oral and written information about the implications of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RGH holds a grant from Grifols for studies of 20% albumin. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}